Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agonist fusion protein for CD40 and OX40 and methods of stimulating the immune system

Agonist fusion protein for CD40 and OX40 and methods of stimulating the immune system

US Patent 10533054 · Granted Jan 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-functional fusion proteins and uses thereof2025
Multi-functional fusion proteins and uses thereof2025
Fusion proteins that facilitate cancer cell destruction2025
PD1-41BBL fusion protein and methods of use thereof2023
Fusion proteins that facilitate cancer cell destruction2022
PD-L1 and PD-L2-based fusion proteins and uses thereof2019
Fusion proteins that facilitate cancer cell destruction2018
Fusion proteins for modulating regulatory and effector T cells2017
PD-L1 and PD-L2-based fusion proteins and uses thereof2017
OX40/TRAIL fusion proteins2015
Fn14/TRAIL fusion proteins and method of treating cancer2012
Fn14/TRAIL fusion proteins2011